Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay

(MedPage Today) -- Regardless of chronic kidney disease (CKD) stage, the potassium-binding agent patiromer (Veltassa) improved serum potassium levels in patients with heart failure, according to a prespecified CKD subanalysis from the DIAMOND trial...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news